US Stock MarketDetailed Quotes

AKRO Akero Therapeutics

Watchlist
  • 29.340
  • +0.940+3.31%
Close Dec 20 16:00 ET
  • 29.340
  • 0.0000.00%
Post 16:11 ET
2.05BMarket Cap-7.76P/E (TTM)

Akero Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
75.27%81.7M
84.52%65.74M
108.51%59.95M
50.12%172.87M
143.40%61.87M
29.16%46.62M
29.12%35.63M
10.37%28.75M
14.14%115.16M
-21.64%25.42M
Selling and administrative expenses
18.67%9.47M
36.30%10.42M
33.56%9.3M
4.02%31.07M
19.45%8.48M
-27.47%7.98M
22.68%7.64M
25.81%6.97M
56.18%29.87M
50.17%7.1M
-General and administrative expense
18.67%9.47M
36.30%10.42M
33.56%9.3M
4.02%31.07M
19.45%8.48M
-27.47%7.98M
22.68%7.64M
25.81%6.97M
56.18%29.87M
50.17%7.1M
Research and development costs
86.96%72.23M
97.68%55.32M
132.48%50.65M
66.27%141.8M
191.44%53.39M
54.00%38.63M
31.00%27.99M
6.21%21.79M
4.31%85.28M
-33.89%18.32M
Operating profit
-75.27%-81.7M
-84.52%-65.74M
-108.51%-59.95M
-50.12%-172.87M
-143.40%-61.87M
-29.16%-46.62M
-29.12%-35.63M
-10.37%-28.75M
-14.14%-115.16M
21.64%-25.42M
Net non-operating interest income expense
29.36%9M
114.56%9.75M
126.21%6.61M
575.98%21.11M
91.06%6.69M
2,246.91%6.96M
8,677.36%4.55M
13,181.82%2.92M
2,765.14%3.12M
3,111.01%3.5M
Non-operating interest income
30.60%10.24M
103.31%10.99M
124.95%7.6M
526.88%24.21M
--7.58M
--7.84M
--5.4M
15,259.09%3.38M
3,443.12%3.86M
----
Non-operating interest expense
40.32%1.25M
43.64%1.23M
116.85%991K
319.35%3.1M
147.79%897K
174.07%888K
1,516.98%857K
--457K
--739K
--362K
Other net income (expense)
Income before tax
-83.33%-72.71M
-80.12%-55.99M
-106.51%-53.34M
-35.46%-151.76M
-139.33%-55.19M
-11.58%-39.66M
-13.43%-31.08M
0.76%-25.83M
-11.17%-112.03M
28.88%-23.06M
Income tax
Net income
-83.33%-72.71M
-80.12%-55.99M
-106.51%-53.34M
-35.46%-151.76M
-139.33%-55.19M
-11.58%-39.66M
-13.43%-31.08M
0.76%-25.83M
-11.17%-112.03M
28.88%-23.06M
Net income continuous Operations
-83.33%-72.71M
-80.12%-55.99M
-106.51%-53.34M
-35.46%-151.76M
-139.33%-55.19M
-11.58%-39.66M
-13.43%-31.08M
0.76%-25.83M
-11.17%-112.03M
28.88%-23.06M
Minority interest income
Net income attributable to the parent company
-83.33%-72.71M
-80.12%-55.99M
-106.51%-53.34M
-35.46%-151.76M
-139.33%-55.19M
-11.58%-39.66M
-13.43%-31.08M
0.76%-25.83M
-11.17%-112.03M
28.88%-23.06M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-83.33%-72.71M
-80.12%-55.99M
-106.51%-53.34M
-35.46%-151.76M
-139.33%-55.19M
-11.58%-39.66M
-13.43%-31.08M
0.76%-25.83M
-11.17%-112.03M
28.88%-23.06M
Basic earnings per share
-47.89%-1.05
-35.00%-0.81
-63.64%-0.9
-0.70%-2.89
-108.16%-1.02
22.83%-0.71
22.08%-0.6
25.68%-0.55
0.69%-2.87
47.31%-0.49
Diluted earnings per share
-47.89%-1.05
-35.00%-0.81
-63.64%-0.9
-0.70%-2.89
-108.16%-1.02
22.83%-0.71
22.08%-0.6
25.68%-0.55
0.69%-2.87
47.31%-0.49
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
--
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 75.27%81.7M84.52%65.74M108.51%59.95M50.12%172.87M143.40%61.87M29.16%46.62M29.12%35.63M10.37%28.75M14.14%115.16M-21.64%25.42M
Selling and administrative expenses 18.67%9.47M36.30%10.42M33.56%9.3M4.02%31.07M19.45%8.48M-27.47%7.98M22.68%7.64M25.81%6.97M56.18%29.87M50.17%7.1M
-General and administrative expense 18.67%9.47M36.30%10.42M33.56%9.3M4.02%31.07M19.45%8.48M-27.47%7.98M22.68%7.64M25.81%6.97M56.18%29.87M50.17%7.1M
Research and development costs 86.96%72.23M97.68%55.32M132.48%50.65M66.27%141.8M191.44%53.39M54.00%38.63M31.00%27.99M6.21%21.79M4.31%85.28M-33.89%18.32M
Operating profit -75.27%-81.7M-84.52%-65.74M-108.51%-59.95M-50.12%-172.87M-143.40%-61.87M-29.16%-46.62M-29.12%-35.63M-10.37%-28.75M-14.14%-115.16M21.64%-25.42M
Net non-operating interest income expense 29.36%9M114.56%9.75M126.21%6.61M575.98%21.11M91.06%6.69M2,246.91%6.96M8,677.36%4.55M13,181.82%2.92M2,765.14%3.12M3,111.01%3.5M
Non-operating interest income 30.60%10.24M103.31%10.99M124.95%7.6M526.88%24.21M--7.58M--7.84M--5.4M15,259.09%3.38M3,443.12%3.86M----
Non-operating interest expense 40.32%1.25M43.64%1.23M116.85%991K319.35%3.1M147.79%897K174.07%888K1,516.98%857K--457K--739K--362K
Other net income (expense)
Income before tax -83.33%-72.71M-80.12%-55.99M-106.51%-53.34M-35.46%-151.76M-139.33%-55.19M-11.58%-39.66M-13.43%-31.08M0.76%-25.83M-11.17%-112.03M28.88%-23.06M
Income tax
Net income -83.33%-72.71M-80.12%-55.99M-106.51%-53.34M-35.46%-151.76M-139.33%-55.19M-11.58%-39.66M-13.43%-31.08M0.76%-25.83M-11.17%-112.03M28.88%-23.06M
Net income continuous Operations -83.33%-72.71M-80.12%-55.99M-106.51%-53.34M-35.46%-151.76M-139.33%-55.19M-11.58%-39.66M-13.43%-31.08M0.76%-25.83M-11.17%-112.03M28.88%-23.06M
Minority interest income
Net income attributable to the parent company -83.33%-72.71M-80.12%-55.99M-106.51%-53.34M-35.46%-151.76M-139.33%-55.19M-11.58%-39.66M-13.43%-31.08M0.76%-25.83M-11.17%-112.03M28.88%-23.06M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -83.33%-72.71M-80.12%-55.99M-106.51%-53.34M-35.46%-151.76M-139.33%-55.19M-11.58%-39.66M-13.43%-31.08M0.76%-25.83M-11.17%-112.03M28.88%-23.06M
Basic earnings per share -47.89%-1.05-35.00%-0.81-63.64%-0.9-0.70%-2.89-108.16%-1.0222.83%-0.7122.08%-0.625.68%-0.550.69%-2.8747.31%-0.49
Diluted earnings per share -47.89%-1.05-35.00%-0.81-63.64%-0.9-0.70%-2.89-108.16%-1.0222.83%-0.7122.08%-0.625.68%-0.550.69%-2.8747.31%-0.49
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion------------
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
MicroStrategy
MSTR
+11.56%
NVIDIA
NVDA
+3.08%
Adobe
ADBE
+2.24%
Salesforce
CRM
+2.21%
Apple
AAPL
+1.88%

Unlock the Full List